Virus Cell Binding
Virus Cell Binding - Related Videos
00:50
What are Viruses?
0 Views •
2019
Overview A virus is a microscopic infectious particle that consists of an RNA or DNA genome enclosed in a protein shell. It is not able to reproduce on its own: it can only make more viruses by entering a cell and using its cellular machinery. When a virus infects a host cell, it removes its protein coat and directs the host’s machinery to transcribe and translate its genetic material. The hijacked cell assembles the replicated components into thousands of viral progeny, which can rupture and...
02:52
Expansion of Mutant Vaccinia Virus in Mammalian Cells
0 Views •
2026
Source: Yuan, M., et al. A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors. J. Vis. Exp. (2016)This video demonstrates the expansion of plaque-derived recombinant virus in adherent mammalian cells. The virus carries a fluorescent reporter in place of a virulent gene, enabling infection tracking. Infected cells are harvested for PCR verification of the genetic modification.
20:47
A Technique to Simultaneously Visualize Virus-Specific CD8+ T Cells and Virus-Infected Cells In situ
0 Views •
Cited by 10 •
2009
A technique combining in situ tetramer staining and in situ hybridization (ISTH) enables visualization, mapping and analysis of the spatial proximity of virus-specific CD8+ T cells to their virus-infected targets, and determination of the quantitative relationships between these immune effectors and targets to infection outcomes.
04:29
Visualizing Transcriptional Suppression in Virus-Infected Cells
0 Views •
2026
Source: Kalveram, B. et al. Using Click Chemistry to Measure the Effect of Viral Infection on Host-Cell RNA Synthesis. J. Vis. Exp. (2013)This video demonstrates the use of click chemistry and fluorescence microscopy to visualize nascent RNA transcription in mammalian cells. It highlights how viral infection suppresses host transcription by comparing fluorescent signals between infected and control cells.
07:02
Quantifying Human Norovirus Virus-like Particles Binding to Commensal Bacteria Using Flow Cytometry
0 Views •
Cited by 8 •
2020
The goal of this protocol is to quantify binding of the eukaryotic pathogen human norovirus to bacteria. After performing an initial virus-bacterium attachment assay, flow cytometry is used to detect virally-bound bacteria within the population.
FAQs
Receptor specificity limits infection to host cells displaying molecules that complement viral surface proteins. Because receptor distribution differs among cell types and tissues, the same virus may interact efficiently with some cells but not others. This molecular selectivity helps explain tissue tropism, or the pattern of cells and tissues that a virus can recognize and potentially infect.
Binding can initiate the next stage of entry by triggering membrane fusion, endocytosis, or another entry process. The particular outcome depends on how receptor engagement connects surface recognition with penetration into the cell. Consequently, attachment is not merely a preliminary contact; it can determine whether the virus proceeds toward productive infection.
Changes in viral surface proteins may modify how those proteins fit complementary cell-surface receptors. That altered molecular recognition can affect which cells a virus binds, how efficiently it attaches, and which tissues may become susceptible. Comparing variants therefore helps researchers evaluate whether changes in binding behavior could influence infection mechanisms or tropism.
Binding assays can be used to compare how viral particles or surface proteins interact with cell-surface molecules, while structural analyses examine the molecular features underlying that interaction. Together, these approaches help identify differences in recognition, compare viral variants, and clarify how receptor engagement relates to subsequent entry processes.
Receptor-blocking strategies aim to prevent viral surface proteins from engaging the molecules needed for attachment. By disrupting this early recognition step, they may reduce the opportunity for membrane fusion, endocytosis, or another entry process to occur. This makes receptor interaction a practical target for antiviral drug development and related intervention strategies.
Because attachment helps determine whether infection can begin, it provides a focused target for neutralizing antibodies, antiviral drugs, receptor-blocking approaches, and vaccines. Researchers can use binding information to assess whether an intervention disrupts recognition or whether a viral variant changes that interaction. These results connect molecular measurements with broader questions about infection and protection.